PCDH17 and cancer: MAL and PCDH17 CpG-rich regions have never been functionally characterised in humans or canines, and, to the best of the authors’ knowledge, the only available data concern the localisation and methylation profile of specific CpGIs in human cancers [37,42,66,67].